Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs

This publication has 11 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• At what level of coronary heart disease risk should a statin be prescribed?
  Current Opinion in Lipidology, 2000
• Debate: at what level of coronary heart disease risk should a statin be prescribed?
  Current Opinion in Lipidology, 2000
• Primary Prevention of Coronary Heart Disease
  Circulation, 1999
• Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
  Atherosclerosis, 1998
• Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
  Circulation, 1998
• Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
  Circulation, 1998
• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998
• Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension
  Atherosclerosis, 1994
• Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?
  JAMA, 1986